Latest Stem cells Stories

PALO ALTO, Calif., May 17, 2013 /PRNewswire/ -- Cellular Biomedicine Group (OTCQB: CBMG) today announced that it has achieved 50% enrollment of the total projected enrollment required for its Phase I trial to evaluate the safety and preliminary efficacy of the medical technology haMPC (Human Adipose-derived Mesenchymal Progenitor Cells) therapy for Knee Osteoarthritis (KOA). To date the trial has had no Severe Adverse Effect (SAE) reported. The Phase I open label clinical research...

BioInformatics LLC announces the release of their newest market report: The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities. Arlington, VA (PRWEB) May 16, 2013 BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004) With barriers to entry low, the number of suppliers in the primary cells market continues to increase. In this study, BioInformatics LLC examines...

In a study just published in STEM CELLS Translational Medicine, researchers have found a new way to increase the survival of stem cells injected into the brain. The discovery might one day prove useful in developing new treatments for neurological disorders — especially brain lesions, which among other things can provoke seizures and indicate multiple sclerosis or certain forms of cancer. Durham, NC (PRWEB) May 16, 2013 Researchers have found a new way to increase the survival of stem...

ROCKVILLE, Md., May 16, 2013 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that CEO and President, Richard Garr, will present at the Annual World Stem Cells and Regenerative Medicine Congress on Thursday, May 23, in London, UK. Mr. Garr's talk, "Understanding the Practicalities of Using Innovative Therapies on Patients," at 2:05 PM, will explore how cell therapies will be used by clinicians and integrated into hospital settings...

Puhua International Hospitals-Temple of Heaven, Beijing, Launches Anti-aging Biotherapy Study. Beijing, China (PRWEB) (PRWEB) May 15, 2013 Puhua International Hospitals (PIHs)-Temple of Heaven (http://puhuahospital.com) (http://www.puhuachina.com) has been a leading international neuroscience and biotechnology center in Beijing, China, for the past 20 years. During that time, Puhua has built and maintained a dominant presence in Beijing in the areas of applied biotechnology, neurology,...

Decreasing the amount of oxygen traditionally used when culturing stem cells for use in neurological therapies could drastically affect their survival rate. In fact, it could double it, according to a new study released today in STEM CELLS Translational Medicine. Durham, NC (PRWEB) May 15, 2013 Decreasing the amount of oxygen traditionally used when culturing stem cells for use in neurological therapies could drastically affect their survival rate. In fact, it could double it, according...

LOS ANGELES, May 15, 2013 /PRNewswire/ -- On May 8, 2013, Dr. Rongxiang Xu, the founder of "human body regenerative restoration science" and a renowned life and medical scientist who is believed to be the only person who has patented the technology for direct regeneration of damaged organs has filed a lawsuit against Dr. Shinya Yamanaka, one of the winners of the 2012 Nobel Prize in Physiology or Medicine in the Superior Court of California, County of San Francisco. The lawsuit filed...

LOS ANGELES, May 15, 2013 /PRNewswire/ -- On May 8, 2013, Dr. Rongxiang Xu, the founder of "human body regenerative restoration science" and a renowned life and medical scientist who is believed to be the only person who has patented the technology for direct regeneration of damaged organs has filed a lawsuit against Dr. Shinya Yamanaka, one of the winners of the 2012 Nobel Prize in Physiology or Medicine in the Superior Court of California, County of San Francisco. The lawsuit filed...

WASHINGTON, May 15, 2013 /PRNewswire-USNewswire/ -- Scientists in Oregon announced today that they had created cloned human embryos, and then destroyed the embryos to extract embryonic stem cells. The cloning technique is essentially the same one used to create Dolly the cloned sheep, with some modifications to make cloning work using human eggs and human cells. This is the first claim of growing human embryonic stem cells from cloned human embryos since the fraudulent claims in...

USCCB Pro-Life Chair Responds to Cloning Breakthrough in Oregon Says Creating Embryos To Destroy Them Objectionable to Non-Catholics Too Notes That Morally Acceptable Scientific Advances Already Addressing Same Goals WASHINGTON, May 15, 2013 /PRNewswire-USNewswire/ -- Human cloning for any purpose is inconsistent with the moral responsibility to "treat each member of the human family as a unique gift of God, as a person with his or her own inherent dignity," said the chairman of...